CoChat

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene

Yergeau, Donald A., Hetherington, Christopher J., Wang, Qing, Zhang, Pu, Sharpe, Arlene H., Binder, Michael, Marín-Padilla, Miguel, Tenen, Daniel G., Speck, Nancy A., Zhang, Dong-Er · 1997 · Nature Genetics

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Abstract

Acute myeloid leukaemia (AML) is a major haematopoietic malignancy characterized by the proliferation of a malignant clone of myeloid progenitor cells. A reciprocal translocation, t(8;21)(q22;q22), observed in the leukaemic cells of approximately 40% of patients with the M2 subtype of AML disrupts both the AML1 (CBFA2) gene on chromosome 21 and the ETO (MTG8) gene on chromosome 8 (refs 3-5). A chimaeric protein is synthesized from one of the derivative chromosomes that contains the N terminus of the AML1 transcription factor, including its DNA-binding domain, fused to most of ETO, a protein of unknown function. We generated mice that mimic human t(8;21) with a "knock-in' strategy. Mice heterozygous for an AML1-ETO allele (AML1-ETO/+) die in midgestation from haemorrhaging in the central nervous system and exhibit a severe block in fetal liver haematopoiesis. This phenotype is very similar to that resulting from homozygous disruption of the AML1 (Cbfa2) or Cbfb genes, indicating that AML1-ETO blocks normal AML1 function. However, yolk sac cells from AML1-ETO/+ mice differentiated into macrophages in haematopoietic colony forming unit (CFU) assays, unlike Cbfa2-/- or Cbfb-/-cells, which form no colonies in vitro. This indicates that AML1-ETO may have other functions besides blocking wild-type AML1, a property that may be important in leukaemogenesis.

Overview

Integrity signals

Registry

Crossref · 10.1038/ng0397-303

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. Rowley, J.D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res. 44, 3159–3168 (1984).

Cited by

Metadata

Authors
Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marín-Padilla, M., Tenen, D. G., Speck, N. A., & Zhang, D.-E.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • Dartmouth College (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Zhang, Dong-Er
Venue
Nature Genetics
Published
1997-03
Volume
15
Issue
3
Pages
303-306
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2054210423
Cited by
346
References
32
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 12 · 2016: 4 · 2015: 10 · 2014: 5 · 2013: 7 · 2012: 15
FWCI
13.45
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ns022897-10)
  • National Cancer Institute (CA 41456, R01CA041456)
  • National Institute of Neurological Disorders and Stroke (NS22897)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (P030AR42689)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
AML1-ETO fusion gene, acute myeloid leukemia, embryonic lethality, macrophage differentiation, leukemogenesis, CBFB
MeSH terms
RUNX1 Translocation Partner 1 Protein, Animals, Chimera, Chromosome Mapping, Chromosomes, Human, Pair 21, Chromosomes, Human, Pair 8, Cloning, Molecular, Crosses, Genetic, DNA-Binding Proteins, Exons, Female, Fetal Death, Hematopoiesis, Genetic Carrier Screening, Humans, Leukemia, Myeloid, Liver, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Proto-Oncogene Proteins, Transcription Factors, Translocation, Genetic, Yolk Sac, Core Binding Factor Alpha 2 Subunit, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.